Simulations Plus Reports First Quarter Fiscal 2025 Financial Results
Simulations Plus (Nasdaq: SLP) reported strong Q1 fiscal 2025 results with total revenue increasing 31% year-over-year to $18.9 million. The growth was primarily driven by software revenue, which rose 41% to $10.7 million (57% of total revenue), while services revenue grew 19% to $8.2 million (43% of total revenue).
Key financial metrics include gross profit of $10.2 million (54% margin), net income of $0.2 million, and diluted EPS of $0.01, compared to $1.9 million and $0.10 in Q1 2024. Adjusted EBITDA reached $4.5 million (24% of revenue). The MonolixSuite™ platform showed strong performance with 43% growth, and the QSP business unit grew 40%. The company maintained its fiscal 2025 guidance of $90-93M in revenue (28-33% growth) with adjusted EBITDA margin of 31-33%.
Simulations Plus (Nasdaq: SLP) ha riportato risultati solidi per il primo trimestre dell'anno fiscale 2025, con il fatturato totale che è aumentato del 31% rispetto all'anno precedente, raggiungendo i 18,9 milioni di dollari. La crescita è stata principalmente trainata dai ricavi software, che sono aumentati del 41% a 10,7 milioni di dollari (57% del fatturato totale), mentre i ricavi dei servizi sono cresciuti del 19% a 8,2 milioni di dollari (43% del fatturato totale).
I principali indicatori finanziari includono un utile lordo di 10,2 milioni di dollari (margine del 54%), un utile netto di 0,2 milioni di dollari e un EPS diluito di 0,01 dollari, rispetto a 1,9 milioni di dollari e 0,10 dollari nel primo trimestre del 2024. L'EBITDA rettificato ha raggiunto i 4,5 milioni di dollari (24% dei ricavi). La piattaforma MonolixSuite™ ha mostrato una forte performance con una crescita del 43%, e l'unità di business QSP è cresciuta del 40%. L'azienda ha mantenuto la sua previsione per l'anno fiscale 2025 di un fatturato compreso tra 90-93 milioni di dollari (crescita del 28-33%) con un margine di EBITDA rettificato del 31-33%.
Simulations Plus (Nasdaq: SLP) reportó resultados sólidos para el primer trimestre del año fiscal 2025, con ingresos totales que aumentaron un 31% interanual, alcanzando los 18,9 millones de dólares. El crecimiento fue impulsado principalmente por los ingresos por software, que crecieron un 41% hasta 10,7 millones de dólares (57% de los ingresos totales), mientras que los ingresos por servicios aumentaron un 19% hasta 8,2 millones de dólares (43% de los ingresos totales).
Las principales métricas financieras incluyen una ganancia bruta de 10,2 millones de dólares (margen del 54%), un ingreso neto de 0,2 millones de dólares y un EPS diluido de 0,01 dólares, en comparación con 1,9 millones de dólares y 0,10 dólares en el primer trimestre de 2024. El EBITDA ajustado alcanzó los 4,5 millones de dólares (24% de los ingresos). La plataforma MonolixSuite™ mostró un sólido rendimiento con un crecimiento del 43%, y la unidad de negocio QSP creció un 40%. La empresa mantuvo su guía para el año fiscal 2025 de ingresos entre 90-93 millones de dólares (crecimiento del 28-33%) con un margen de EBITDA ajustado del 31-33%.
Simulations Plus (Nasdaq: SLP)는 2025 회계연도 1분기에 총 수익이 전년 대비 31% 증가한 1890만 달러라는 강력한 실적을 발표했습니다. 이 성장은 주로 소프트웨어 수익에 의해 주도되었으며, 이는 41% 상승하여 1070만 달러(총 수익의 57%)에 이르렀고, 서비스 수익은 19% 증가하여 820만 달러(총 수익의 43%)에 도달했습니다.
주요 재무 지표에는 1020만 달러의 총 이익(54% 마진), 20만 달러의 순이익, 0.01달러의 희석 주당 순이익(EPS)이 포함되며, 이는 2024년 1분기의 190만 달러 및 0.10달러와 비교됩니다. 조정된 EBITDA는 450만 달러(수익의 24%)에 도달했습니다. MonolixSuite™ 플랫폼은 43% 성장률로 강력한 성과를 보였으며, QSP 사업 부문은 40% 성장했습니다. 회사는 2025 회계연도의 수익 목표를 9000만-9300만 달러(28-33% 성장)와 조정된 EBITDA 마진을 31-33%로 유지하였습니다.
Simulations Plus (Nasdaq: SLP) a publié de solides résultats pour le premier trimestre de l'exercice 2025, avec des revenus totaux en hausse de 31% par rapport à l'année précédente, atteignant 18,9 millions de dollars. Cette croissance a été principalement soutenue par les recettes logicielles, qui ont augmenté de 41% pour atteindre 10,7 millions de dollars (57% des revenus totaux), tandis que les revenus des services ont crû de 19% à 8,2 millions de dollars (43% des revenus totaux).
Les principaux indicateurs financiers comprennent un bénéfice brut de 10,2 millions de dollars (marge de 54%), un bénéfice net de 0,2 million de dollars et un BPA dilué de 0,01 dollar, par rapport à 1,9 million de dollars et 0,10 dollar dans le premier trimestre 2024. L'EBITDA ajusté a atteint 4,5 millions de dollars (24% des revenus). La plateforme MonolixSuite™ a enregistré une solide performance avec une croissance de 43%, et l'unité commerciale QSP a crû de 40%. L'entreprise a maintenu ses prévisions pour l'exercice 2025 avec des revenus de 90 à 93 millions de dollars (croissance de 28 à 33%) et une marge d'EBITDA ajustée de 31 à 33%.
Simulations Plus (Nasdaq: SLP) hat für das erste Quartal des Geschäftsjahres 2025 starke Ergebnisse gemeldet, wobei der Gesamtumsatz im Vergleich zum Vorjahr um 31% auf 18,9 Millionen US-Dollar gestiegen ist. Das Wachstum wurde hauptsächlich durch den Softwareumsatz angetrieben, der um 41% auf 10,7 Millionen US-Dollar (57% des Gesamtumsatzes) angestiegen ist, während die Dienstleistungsumsätze um 19% auf 8,2 Millionen US-Dollar (43% des Gesamtumsatzes) gewachsen sind.
Wichtige finanzielle Kennzahlen umfassen einen Bruttogewinn von 10,2 Millionen US-Dollar (54% Marge), einen Nettogewinn von 0,2 Millionen US-Dollar und ein verwässertes EPS von 0,01 US-Dollar, im Vergleich zu 1,9 Millionen US-Dollar und 0,10 US-Dollar im ersten Quartal 2024. Das bereinigte EBITDA erreichte 4,5 Millionen US-Dollar (24% des Umsatzes). Die MonolixSuite™-Plattform zeigte eine starke Leistung mit einem Wachstum von 43%, und die Geschäftsbereich QSP wuchs um 40%. Das Unternehmen hat seine Prognose für das Geschäftsjahr 2025 bei einem Umsatz von 90 bis 93 Millionen US-Dollar (28-33% Wachstum) und einer bereinigten EBITDA-Marge von 31-33% beibehalten.
- Total revenue increased 31% YoY to $18.9M
- Software revenue grew 41% to $10.7M
- Services revenue increased 19% to $8.2M
- MonolixSuite platform achieved 43% growth
- QSP business unit recorded 40% growth
- Adjusted EBITDA improved to $4.5M (24% of revenue) from $3.4M (23%)
- Net income declined to $0.2M from $1.9M YoY
- Diluted EPS decreased to $0.01 from $0.10 YoY
- Services segment faced temporary headwinds due to client-driven delays
- Ongoing funding challenges and cost constraints in pharma/biotech sectors
Insights
Total revenue up
First Quarter 2025 Financial Highlights (compared to first quarter 2024)
-
Total revenue increased
31% to$18.9 million -
Software revenue increased
41% to , representing$10.7 million 57% of total revenue -
Services revenue increased
19% to , representing$8.2 million 43% of total revenue -
Gross profit of
; gross margin was$10.2 million 54% -
Net income of
and diluted EPS of$0.2 million compared to net income of$0.01 and diluted EPS of$1.9 million $0.10 -
Adjusted EBITDA of
, representing$4.5 million 24% of total revenue, compared to , representing$3.4 million 23% of total revenue -
Adjusted net income of
and adjusted diluted EPS of$3.4 million , compared to adjusted net income of$0.17 and adjusted diluted EPS of$3.7 million $0.18
Management Commentary
“We are off to a strong start to fiscal 2025 with total revenue increasing by
“Services revenue increased
“Overall, our team achieved solid results despite ongoing funding challenges and cost constraints in the pharma and biotech sectors. The integration of our Adaptive Learning and Insights (ALI) and MC business units is progressing well. For fiscal 2025, we expect momentum to be strongest in the back half of the year, which puts us on track to meet our stated guidance.”
Fiscal 2025 Guidance
|
|
Fiscal 2025 Guidance |
Revenue |
|
|
Revenue growth |
|
28 - |
Software mix |
|
55 - |
Adjusted EBITDA margin |
|
31 - |
Adjusted diluted EPS |
|
|
Webcast and Conference Call Details
Shawn O’Connor, Chief Executive Officer, and Will Frederick, Chief Financial and Operating Officer, will host a conference call and webcast today at 5 p.m. Eastern Time to discuss the details of Simulations Plus’ performance for the quarter and certain forward-looking information. The call may be accessed by registering here or by calling 1-877-451-6152 (domestic) or 1-201-389-0879 (international) or by clicking on this Call me™ link to request a return call. The webcast can be accessed on the investor relations page of the Simulations Plus website https://www.simulations-plus.com/investorscorporate-profile/corporate-profile/ where it will also be available for replay approximately one hour following the call.
Non-GAAP Financial Measures
This press release contains “non-GAAP financial measures,” which are measures that either exclude or include amounts that are not excluded or included in the most directly comparable measures calculated and presented in accordance with
A further explanation and reconciliation of these non-GAAP financial measures is included below and in the financial tables in this release.
The Company believes that the non-GAAP financial measures presented facilitate an understanding of operating performance and provide a meaningful comparison of its results between periods. The Company’s management uses non-GAAP financial measures to, among other things, evaluate its ongoing operations in relation to historical results, for internal planning and forecasting purposes and in the calculation of performance-based compensation. Adjusted EBITDA and Adjusted Diluted EPS represent measures that we believe are customarily used by investors and analysts to evaluate the financial performance of companies in addition to the GAAP measures that we present. Our management also believes that these measures are useful in evaluating our core operating results. However, Adjusted EBITDA and Adjusted Diluted EPS are not measures of financial performance under accounting principles generally accepted in
Please note that the Company has not reconciled the adjusted EBITDA or adjusted diluted earnings per share forward-looking guidance included in this press release to the most directly comparable GAAP measures because this cannot be done without unreasonable effort due to the variability and low visibility with respect to costs related to acquisitions, financings, and employee stock compensation programs, which are potential adjustments to future earnings. We expect the variability of these items to have a potentially unpredictable, and a potentially significant, impact on our future GAAP financial results.
Adjusted EBITDA
Adjusted EBITDA represents net income excluding the effect of interest expense (income), provision (benefit) for income taxes, amortization expense, intangible asset amortization, equity-based compensation expense, loss (gain) on currency exchange, goodwill impairment, change in fair value of contingent consideration, reorganization expense, acquisition and integration expense and other items not indicative of our ongoing operating performance.
Adjusted Net Income and Adjusted Diluted EPS
Adjusted net income and adjusted diluted earnings per share exclude the effect of amortization expense, equity-based compensation expense, loss (gain) on currency exchange, goodwill impairment, change in fair value of contingent consideration, reorganization expense, acquisition and integration expense and other items not indicative of our ongoing operating performance as well as the income tax provision adjustment for such charges.
The Company excludes the above items because they are outside of the Company’s normal operations and/or, in certain cases, are difficult to forecast accurately for future.
About Simulations Plus
With more than 25 years of experience serving clients globally, Simulations Plus stands as a premier provider in the biopharma sector, offering advanced software and consulting services that enhance drug discovery, development, research, clinical trial operations, regulatory submissions, and commercialization. Our comprehensive biosimulation solutions integrate artificial intelligence/machine learning (AI/ML), physiologically based pharmacokinetics, physiologically based biopharmaceutics, quantitative systems pharmacology/toxicology, and population PK/PD modeling approaches. We also deliver simulation-enabled performance and intelligence solutions alongside medical communications support for clinical and commercial drug development. Our cutting-edge technology is licensed and utilized by leading pharmaceutical, biotechnology, and regulatory agencies worldwide. For more information, visit our website at www.simulations-plus.com. Follow us on LinkedIn | X | YouTube.
Environmental, Social, and Governance
We focus our Environmental, Social, and Governance (ESG) efforts where we can have the most positive impact. To learn more about our latest initiatives and priorities, please visit our website to read our 2023 ESG update.
Forward-Looking Statements
Except for historical information, the matters discussed in this press release are forward-looking statements that involve risks and uncertainties. Words like “believe,” “expect,” and “anticipate” mean that these are our best estimates as of this writing, but there can be no assurances that expected or anticipated results or events will actually take place, so our actual future results could differ significantly from those statements. Factors that could cause or contribute to such differences include, but are not limited to: our ability to integrate our ALI and MC business units, our ability to meet our stated guidance, our ability to maintain our competitive advantages, acceptance of new software and improved versions of our existing software by our customers, the general economics of the pharmaceutical industry, our ability to finance growth, our ability to continue to attract and retain highly qualified technical staff, market conditions, macroeconomic factors, and a sustainable market. Further information on our risk factors is contained in our quarterly and annual reports and filed with the
SIMULATIONS PLUS, INC.
|
||||||||
|
|
Three Months Ended |
||||||
(in thousands, except per common share amounts) |
|
November 30, 2024 |
|
November 30, 2023 |
||||
Revenues |
|
|
|
|
||||
Software |
|
$ |
10,715 |
|
|
$ |
7,589 |
|
Services |
|
|
8,209 |
|
|
|
6,911 |
|
Total revenues |
|
|
18,924 |
|
|
|
14,500 |
|
Cost of revenues |
|
|
|
|
||||
Software |
|
|
2,638 |
|
|
|
991 |
|
Services |
|
|
6,068 |
|
|
|
3,661 |
|
Total cost of revenues |
|
|
8,706 |
|
|
|
4,652 |
|
Gross profit |
|
|
10,218 |
|
|
|
9,848 |
|
Operating expenses |
|
|
|
|
||||
Research and development |
|
|
1,848 |
|
|
|
1,217 |
|
Sales and marketing |
|
|
2,851 |
|
|
|
1,989 |
|
General and administrative |
|
|
5,393 |
|
|
|
5,682 |
|
Total operating expenses |
|
|
10,092 |
|
|
|
8,888 |
|
Income from operations |
|
|
126 |
|
|
|
960 |
|
Other income |
|
|
144 |
|
|
|
1,446 |
|
|
|
|
|
|
||||
Income before income taxes |
|
|
270 |
|
|
|
2,406 |
|
Provision for income taxes |
|
|
(64 |
) |
|
|
(461 |
) |
Net income |
|
$ |
206 |
|
|
$ |
1,945 |
|
|
|
|
|
|
||||
Earnings per share |
|
|
|
|
||||
Basic |
|
$ |
0.01 |
|
|
$ |
0.10 |
|
Diluted |
|
$ |
0.01 |
|
|
$ |
0.10 |
|
|
|
|
|
|
||||
Weighted-average common shares outstanding |
|
|
|
|
||||
Basic |
|
|
20,068 |
|
|
|
19,947 |
|
Diluted |
|
|
20,266 |
|
|
|
20,279 |
|
|
|
|
|
|
||||
Other comprehensive (loss) income, net of tax |
|
|
|
|
||||
Foreign currency translation adjustments |
|
|
(42 |
) |
|
|
(54 |
) |
Unrealized gains on available-for-sale securities |
|
$ |
4 |
|
|
$ |
— |
|
Comprehensive income |
|
$ |
168 |
|
|
$ |
1,891 |
|
SIMULATIONS PLUS, INC.
|
||||||||
(in thousands, except share and per share amounts) |
|
November 30, 2024 |
|
August 31, 2024 |
||||
ASSETS |
|
|
|
|
||||
Current assets |
|
|
|
|
||||
Cash and cash equivalents |
|
$ |
6,187 |
|
|
$ |
10,311 |
|
Accounts receivable, net of allowance for credit losses of |
|
|
12,804 |
|
|
|
9,136 |
|
Prepaid income taxes |
|
|
2,327 |
|
|
|
2,197 |
|
Prepaid expenses and other current assets |
|
|
7,098 |
|
|
|
7,753 |
|
Short-term investments |
|
|
11,983 |
|
|
|
9,944 |
|
Total current assets |
|
|
40,399 |
|
|
|
39,341 |
|
Long-term assets |
|
|
|
|
||||
Capitalized computer software development costs, net of accumulated amortization of |
|
|
12,441 |
|
|
|
12,499 |
|
Property and equipment, net |
|
|
819 |
|
|
|
812 |
|
Operating lease right-of-use assets |
|
|
1,342 |
|
|
|
1,027 |
|
Intellectual property, net of accumulated amortization of |
|
|
22,045 |
|
|
|
23,130 |
|
Other intangible assets, net of accumulated amortization of |
|
|
23,076 |
|
|
|
23,210 |
|
Goodwill |
|
|
96,305 |
|
|
|
96,078 |
|
Other assets |
|
|
489 |
|
|
|
542 |
|
Total assets |
|
$ |
196,916 |
|
|
$ |
196,639 |
|
LIABILITIES AND SHAREHOLDERS' EQUITY |
|
|
|
|
||||
Current liabilities |
|
|
|
|
||||
Accounts payable |
|
$ |
1,120 |
|
|
$ |
602 |
|
Accrued compensation |
|
|
1,882 |
|
|
|
4,513 |
|
Accrued expenses |
|
|
580 |
|
|
|
2,043 |
|
Contracts payable - current portion |
|
|
2,440 |
|
|
|
2,440 |
|
Operating lease liability - current portion |
|
|
485 |
|
|
|
475 |
|
Deferred revenue |
|
|
3,231 |
|
|
|
1,996 |
|
Total current liabilities |
|
|
9,738 |
|
|
|
12,069 |
|
Long-term liabilities |
|
|
|
|
||||
Deferred income taxes, net |
|
|
1,648 |
|
|
|
1,608 |
|
Operating lease liability - net of current portion |
|
|
835 |
|
|
|
531 |
|
Total liabilities |
|
|
12,221 |
|
|
|
14,208 |
|
Commitments and contingencies |
|
|
— |
|
|
|
— |
|
Shareholders' equity |
|
|
|
|
||||
Preferred stock, |
|
$ |
— |
|
|
$ |
— |
|
Common stock, |
|
|
154,424 |
|
|
|
152,328 |
|
Retained earnings |
|
|
30,560 |
|
|
|
30,354 |
|
Accumulated other comprehensive loss |
|
|
(289 |
) |
|
|
(251 |
) |
Total shareholders' equity |
|
|
184,695 |
|
|
|
182,431 |
|
Total liabilities and shareholders' equity |
|
$ |
196,916 |
|
|
$ |
196,639 |
|
SIMULATIONS PLUS, INC.
|
||||||||||||||||||||||||||||||||||||||||||||
(in millions except earnings per share amounts) |
||||||||||||||||||||||||||||||||||||||||||||
|
|
FY23 |
|
FY24 |
|
FY25 |
|
FY23 |
|
FY24 |
||||||||||||||||||||||||||||||||||
|
Q1 |
|
Q2 |
|
Q3 |
|
Q4 |
|
Q1 |
|
Q2 |
|
Q3 |
|
Q4 |
|
Q1 |
|
Full Year |
|
Full Year |
|||||||||||||||||||||||
Revenue |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||||||||||
Software |
|
$ |
6.074 |
|
|
$ |
10.487 |
|
|
$ |
10.632 |
|
|
$ |
9.324 |
|
|
$ |
7.589 |
|
|
$ |
11.614 |
|
|
$ |
11.908 |
|
|
$ |
9.913 |
|
|
$ |
10.715 |
|
|
$ |
36.517 |
|
|
$ |
41.024 |
|
Services |
|
$ |
5.890 |
|
|
$ |
5.263 |
|
|
$ |
5.602 |
|
|
$ |
6.305 |
|
|
$ |
6.911 |
|
|
$ |
6.691 |
|
|
$ |
6.636 |
|
|
$ |
8.751 |
|
|
$ |
8.209 |
|
|
$ |
23.060 |
|
|
$ |
28.989 |
|
Total |
|
$ |
11.964 |
|
|
$ |
15.750 |
|
|
$ |
16.234 |
|
|
$ |
15.629 |
|
|
$ |
14.500 |
|
|
$ |
18.305 |
|
|
$ |
18.544 |
|
|
$ |
18.664 |
|
|
$ |
18.924 |
|
|
$ |
59.577 |
|
|
$ |
70.013 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||||||||||
Gross Margin |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||||||||||
Software |
|
|
85.4 |
% |
|
|
92.0 |
% |
|
|
91.5 |
% |
|
|
89.4 |
% |
|
|
86.9 |
% |
|
|
88.4 |
% |
|
|
88.2 |
% |
|
|
72.4 |
% |
|
|
75.4 |
% |
|
|
90.1 |
% |
|
|
84.2 |
% |
Services |
|
|
69.7 |
% |
|
|
66.2 |
% |
|
|
63.4 |
% |
|
|
62.1 |
% |
|
|
47.0 |
% |
|
|
44.2 |
% |
|
|
41.4 |
% |
|
|
-4.0 |
% |
|
|
26.1 |
% |
|
|
65.3 |
% |
|
|
29.7 |
% |
Total |
|
|
77.7 |
% |
|
|
83.4 |
% |
|
|
81.8 |
% |
|
|
78.4 |
% |
|
|
67.9 |
% |
|
|
72.2 |
% |
|
|
71.5 |
% |
|
|
36.6 |
% |
|
|
54.0 |
% |
|
|
80.5 |
% |
|
|
61.6 |
% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||||||||||
Income from operations |
|
$ |
0.878 |
|
|
$ |
4.034 |
|
|
$ |
4.097 |
|
|
$ |
(0.284 |
) |
|
$ |
0.960 |
|
|
$ |
4.442 |
|
|
$ |
1.880 |
|
|
$ |
(1.151 |
) |
|
$ |
0.126 |
|
|
$ |
8.725 |
|
|
$ |
6.131 |
|
Operating Margin |
|
|
7.3 |
% |
|
|
25.6 |
% |
|
|
25.2 |
% |
|
|
-1.8 |
% |
|
|
6.6 |
% |
|
|
24.3 |
% |
|
|
10.1 |
% |
|
|
-6.2 |
% |
|
|
0.7 |
% |
|
|
14.6 |
% |
|
|
8.8 |
% |
Net Income |
|
$ |
1.245 |
|
|
$ |
4.174 |
|
|
$ |
4.008 |
|
|
$ |
0.534 |
|
|
$ |
1.945 |
|
|
$ |
4.029 |
|
|
$ |
3.137 |
|
|
$ |
0.843 |
|
|
$ |
0.206 |
|
|
$ |
9.961 |
|
|
$ |
9.954 |
|
Diluted Earnings Per Share |
|
$ |
0.06 |
|
|
$ |
0.20 |
|
|
$ |
0.20 |
|
|
$ |
0.03 |
|
|
$ |
0.10 |
|
|
$ |
0.20 |
|
|
$ |
0.15 |
|
|
$ |
0.04 |
|
|
$ |
0.01 |
|
|
$ |
0.49 |
|
|
$ |
0.49 |
|
Adjusted EBITDA |
|
$ |
3.032 |
|
|
$ |
6.179 |
|
|
$ |
6.494 |
|
|
$ |
4.917 |
|
|
$ |
3.388 |
|
|
$ |
7.135 |
|
|
$ |
5.586 |
|
|
$ |
4.148 |
|
|
$ |
4.493 |
|
|
$ |
20.622 |
|
|
$ |
20.257 |
|
Adjusted Diluted EPS |
|
$ |
0.14 |
|
|
$ |
0.29 |
|
|
$ |
0.30 |
|
|
$ |
0.29 |
|
|
$ |
0.18 |
|
|
$ |
0.32 |
|
|
$ |
0.27 |
|
|
$ |
0.18 |
|
|
$ |
0.17 |
|
|
$ |
0.67 |
|
|
$ |
0.53 |
|
Cash Flow from Operations |
|
$ |
4.700 |
|
|
$ |
5.548 |
|
|
$ |
8.548 |
|
|
$ |
3.060 |
|
|
$ |
0.162 |
|
|
$ |
5.810 |
|
|
$ |
5.700 |
|
|
$ |
1.600 |
|
|
$ |
(1.274 |
) |
|
$ |
21.856 |
|
|
$ |
13.320 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||||||||||
Revenue Breakdown by Region |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||||||||||
|
|
$ |
8.500 |
|
|
$ |
10.589 |
|
|
$ |
10.774 |
|
|
$ |
10.954 |
|
|
$ |
10.891 |
|
|
$ |
12.461 |
|
|
$ |
12.428 |
|
|
$ |
14.700 |
|
|
$ |
14.469 |
|
|
$ |
40.817 |
|
|
$ |
50.473 |
|
EMEA |
|
|
2.130 |
|
|
|
3.618 |
|
|
|
3.358 |
|
|
|
2.607 |
|
|
|
2.302 |
|
|
|
4.665 |
|
|
|
4.513 |
|
|
|
2.600 |
|
|
|
2.720 |
|
|
|
11.713 |
|
|
|
14.072 |
|
|
|
|
1.334 |
|
|
|
1.543 |
|
|
|
2.102 |
|
|
|
2.068 |
|
|
|
1.307 |
|
|
|
1.179 |
|
|
|
1.603 |
|
|
|
1.400 |
|
|
|
1.735 |
|
|
|
7.047 |
|
|
|
5.468 |
|
Total |
|
$ |
11.964 |
|
|
$ |
15.750 |
|
|
$ |
16.234 |
|
|
$ |
15.629 |
|
|
$ |
14.500 |
|
|
$ |
18.305 |
|
|
$ |
18.544 |
|
|
$ |
18.700 |
|
|
$ |
18.924 |
|
|
$ |
59.577 |
|
|
$ |
70.013 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||||||||||
Software Performance Metrics |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||||||||||
Avg. Revenue per Customer (in thousands) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||||||||||
Commercial |
|
$ |
68.0 |
|
|
$ |
110.0 |
|
|
$ |
97.0 |
|
|
|
88.0 |
|
|
$ |
79.0 |
|
|
$ |
113.0 |
|
|
$ |
97.0 |
|
|
$ |
89.0 |
|
|
$ |
94.0 |
|
|
|
|
|
||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||||||||||
Services Performance Metrics |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||||||||||
Backlog (in millions) |
|
$ |
15.826 |
|
|
$ |
15.369 |
|
|
$ |
15.667 |
|
|
$ |
19.485 |
|
|
$ |
18.910 |
|
|
$ |
18.041 |
|
|
$ |
19.602 |
|
|
$ |
14.091 |
|
|
$ |
17.254 |
|
|
|
|
|
(1) |
|
Numbers may not add due to rounding |
SIMULATIONS PLUS, INC.
|
|||||||||||||||||||||||||||||||||||||||||||
(in millions) |
|||||||||||||||||||||||||||||||||||||||||||
|
|
FY23 |
|
FY 2024 |
FY25 |
|
FY23 |
|
FY24 |
||||||||||||||||||||||||||||||||||
|
|
Q1 |
|
Q2 |
|
Q3 |
|
Q4 |
|
Q1 |
|
Q2 |
|
Q3 |
|
Q4 |
Q1 |
|
Full Year |
|
Full Year |
||||||||||||||||||||||
Net Income |
|
$ |
1.245 |
|
|
$ |
4.174 |
|
|
$ |
4.008 |
|
|
$ |
0.534 |
|
|
$ |
1.945 |
|
|
$ |
4.029 |
|
|
$ |
3.137 |
|
|
$ |
0.843 |
|
$ |
0.206 |
|
|
$ |
9.961 |
|
|
$ |
9.954 |
|
Excluding: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||||||||||
Interest income and expense, net |
|
|
(0.771 |
) |
|
|
(0.985 |
) |
|
|
(1.120 |
) |
|
|
(1.255 |
) |
|
|
(1.292 |
) |
|
|
(1.348 |
) |
|
|
(1.522 |
) |
|
|
(0.213 |
) |
|
(0.159 |
) |
|
|
(4.131 |
) |
|
|
(4.375 |
) |
Provision for income taxes |
|
|
0.373 |
|
|
|
0.894 |
|
|
|
0.932 |
|
|
|
(0.465 |
) |
|
|
0.461 |
|
|
|
1.223 |
|
|
|
0.753 |
|
|
|
0.020 |
|
|
0.064 |
|
|
|
1.734 |
|
|
|
2.457 |
|
Depreciation and amortization |
|
|
0.923 |
|
|
|
0.935 |
|
|
|
0.945 |
|
|
|
1.052 |
|
|
|
1.091 |
|
|
|
1.105 |
|
|
|
1.263 |
|
|
|
2.206 |
|
|
2.265 |
|
|
|
3.855 |
|
|
|
5.665 |
|
Stock-based compensation |
|
|
0.886 |
|
|
|
1.160 |
|
|
|
1.052 |
|
|
|
1.130 |
|
|
|
1.303 |
|
|
|
1.585 |
|
|
|
1.665 |
|
|
|
1.387 |
|
|
1.589 |
|
|
|
4.228 |
|
|
|
5.940 |
|
(Gain) loss on currency exchange |
|
|
0.031 |
|
|
|
(0.049 |
) |
|
|
0.277 |
|
|
|
0.216 |
|
|
|
(0.044 |
) |
|
|
0.098 |
|
|
|
(0.009 |
) |
|
|
(0.431 |
) |
|
0.015 |
|
|
|
0.475 |
|
|
|
(0.386 |
) |
Impairment of other intangibles |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
0.500 |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
— |
|
|
|
0.500 |
|
|
|
— |
|
Change in value of contingent consideration |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
0.680 |
|
|
|
(0.110 |
) |
|
|
0.440 |
|
|
|
(0.599 |
) |
|
|
(1.370 |
) |
|
— |
|
|
|
0.680 |
|
|
|
(1.639 |
) |
Mergers & Acquisitions expense |
|
|
0.345 |
|
|
|
0.050 |
|
|
|
0.400 |
|
|
|
2.519 |
|
|
|
0.034 |
|
|
|
0.003 |
|
|
|
0.898 |
|
|
|
1.706 |
|
|
0.255 |
|
|
|
3.314 |
|
|
|
2.641 |
|
Adjusted EBITDA |
|
$ |
3.032 |
|
|
$ |
6.179 |
|
|
$ |
6.494 |
|
|
$ |
4.917 |
|
|
$ |
3.388 |
|
|
$ |
7.135 |
|
|
$ |
5.586 |
|
|
$ |
4.148 |
|
$ |
4.493 |
|
|
$ |
20.622 |
|
|
$ |
20.257 |
|
(1) |
|
Numbers may not add due to rounding |
SIMULATIONS PLUS, INC.
|
||||||||||||||||||||||||||||||||||||||||||||
(in millions, except Diluted EPS and Adjusted Diluted EPS) |
||||||||||||||||||||||||||||||||||||||||||||
|
|
FY23 |
|
FY 2024 |
|
FY25 |
|
FY23 |
|
FY24 |
||||||||||||||||||||||||||||||||||
|
|
Q1 |
|
Q2 |
|
Q3 |
|
Q4 |
|
Q1 |
|
Q2 |
|
Q3 |
|
Q4 |
|
Q1 |
|
Full Year |
|
Full Year |
||||||||||||||||||||||
Net Income (GAAP) |
|
$ |
1.245 |
|
|
$ |
4.174 |
|
|
$ |
4.008 |
|
|
$ |
0.534 |
|
|
$ |
1.945 |
|
|
$ |
4.029 |
|
|
$ |
3.137 |
|
|
$ |
0.843 |
|
|
$ |
0.206 |
|
|
$ |
9.961 |
|
|
$ |
9.954 |
|
Excluding: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||||||||||
Amortization |
|
|
0.834 |
|
|
|
0.838 |
|
|
|
0.847 |
|
|
|
0.950 |
|
|
|
0.991 |
|
|
|
0.991 |
|
|
|
1.122 |
|
|
|
2.059 |
|
|
|
2.130 |
|
|
|
3.469 |
|
|
|
5.163 |
|
Stock-based compensation |
|
|
0.886 |
|
|
|
1.160 |
|
|
|
1.052 |
|
|
|
1.130 |
|
|
|
1.303 |
|
|
|
1.585 |
|
|
|
1.665 |
|
|
|
1.387 |
|
|
|
1.589 |
|
|
|
4.228 |
|
|
|
5.940 |
|
(Gain) loss on currency exchange |
|
|
0.031 |
|
|
|
(0.049 |
) |
|
|
0.277 |
|
|
|
0.216 |
|
|
|
(0.044 |
) |
|
|
0.098 |
|
|
|
(0.009 |
) |
|
|
(0.431 |
) |
|
|
0.015 |
|
|
|
0.475 |
|
|
|
(0.386 |
) |
Mergers & Acquisitions expense |
|
|
0.345 |
|
|
|
0.050 |
|
|
|
0.400 |
|
|
|
0.926 |
|
|
|
0.034 |
|
|
|
0.003 |
|
|
|
0.898 |
|
|
|
1.706 |
|
|
|
0.255 |
|
|
|
1.721 |
|
|
|
2.641 |
|
Immunetrics transaction costs |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
1.586 |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
1.586 |
|
|
|
— |
|
Change in value of contingent consideration |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
0.680 |
|
|
|
(0.110 |
) |
|
|
0.440 |
|
|
|
(0.599 |
) |
|
|
(1.370 |
) |
|
|
— |
|
|
|
0.680 |
|
|
|
(1.639 |
) |
Reorganization expense |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
0.258 |
|
|
|
— |
|
|
|
— |
|
Cognigen trade name write-off |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
0.500 |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
0.500 |
|
|
|
— |
|
Tax effect on above adjustments |
|
|
(0.483 |
) |
|
|
(0.293 |
) |
|
|
(0.486 |
) |
|
|
(0.615 |
) |
|
|
(0.417 |
) |
|
|
(0.746 |
) |
|
|
(0.603 |
) |
|
|
(0.554 |
) |
|
|
(1.007 |
) |
|
|
(1.877 |
) |
|
|
(2.320 |
) |
Adjusted Net income (Non-GAAP) |
|
$ |
2.858 |
|
|
$ |
5.880 |
|
|
$ |
6.098 |
|
|
$ |
5.907 |
|
|
$ |
3.702 |
|
|
$ |
6.400 |
|
|
$ |
5.611 |
|
|
$ |
3.640 |
|
|
$ |
3.446 |
|
|
$ |
20.743 |
|
|
$ |
19.353 |
|
Weighted-avg. common shares outstanding: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||||||||||
Diluted |
|
|
20.825 |
|
|
|
20.529 |
|
|
|
20.355 |
|
|
|
20.369 |
|
|
|
20.279 |
|
|
|
20.315 |
|
|
|
20.433 |
|
|
|
20.338 |
|
|
|
20.266 |
|
|
|
20.465 |
|
|
|
20.301 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||||||||||
Diluted EPS (GAAP) |
|
$ |
0.06 |
|
|
$ |
0.20 |
|
|
$ |
0.20 |
|
|
$ |
0.03 |
|
|
$ |
0.10 |
|
|
$ |
0.20 |
|
|
$ |
0.15 |
|
|
$ |
0.04 |
|
|
$ |
0.01 |
|
|
$ |
0.49 |
|
|
$ |
0.49 |
|
Adjusted Diluted EPS (Non-GAAP) |
|
$ |
0.14 |
|
|
$ |
0.29 |
|
|
$ |
0.30 |
|
|
$ |
0.29 |
|
|
$ |
0.18 |
|
|
$ |
0.32 |
|
|
$ |
0.27 |
|
|
$ |
0.18 |
|
|
$ |
0.17 |
|
|
$ |
1.01 |
|
|
$ |
0.95 |
|
(1) |
|
Numbers may not add due to rounding |
View source version on businesswire.com: https://www.businesswire.com/news/home/20250107123533/en/
Investor Relations Contact:
Lisa Fortuna
Financial Profiles
310-622-8251
slp@finprofiles.com
Source: Simulations Plus, Inc.
FAQ
What was SLP's revenue growth in Q1 fiscal 2025?
How much did SLP's software revenue grow in Q1 2025?
What is SLP's revenue guidance for fiscal 2025?
How did SLP's MonolixSuite perform in Q1 2025?
What were SLP's earnings per share in Q1 fiscal 2025?